Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Group ESCSD. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503–626.

Article  CAS  PubMed  Google Scholar 

Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J. 2014;35(39):2733–79.

Article  PubMed  Google Scholar 

Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2020;142(25):e558–e631.

PubMed  Google Scholar 

Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–60.

Article  PubMed  Google Scholar 

Nagueh SF, Phelan D, Abraham T, Armour A, Desai MY, Dragulescu A, et al. Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: an update from the American society of Echocardiography, in collaboration with the American society of nuclear cardiology, the society for cardiovascular magnetic resonance, and the society of cardiovascular computed tomography. J Am Soc Echocardiogr. 2022;35(6):533–69.

Article  PubMed  Google Scholar 

Pelliccia A, Sharma S, Gati S, Back M, Borjesson M, Caselli S, Group ESCSD. 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17–96.

Article  CAS  PubMed  Google Scholar 

Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2021;42(16):1554–68.

Article  PubMed  PubMed Central  Google Scholar 

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Group ESCSD. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.

Article  PubMed  Google Scholar 

Sipola P, Magga J, Husso M, Jaaskelainen P, Peuhkurinen K, Kuusisto J. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation. Eur Radiol. 2011;21(7):1383–9.

Article  PubMed  Google Scholar 

Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339(6):364–9.

Article  CAS  PubMed  Google Scholar 

Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults. Circulation. 1995;92(4):785–9.

Article  CAS  PubMed  Google Scholar 

Maron BJ, Spirito P, Roman MJ, Paranicas M, Okin PM, Best LG, et al. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American indians aged 51 to 77 years (the strong heart study). Am J Cardiol. 2004;93(12):1510–4.

Article  PubMed  Google Scholar 

Nistri S, Thiene G, Basso C, Corrado D, Vitolo A, Maron BJ. Screening for hypertrophic cardiomyopathy in a young male military population. Am J Cardiol. 2003;91(8):1021–3. A8.

Article  PubMed  Google Scholar 

Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med. 2004;116(1):14–8.

Article  PubMed  Google Scholar 

Bick AG, Flannick J, Ito K, Cheng S, Vasan RS, Parfenov MG, et al. Burden of rare sarcomere gene variants in the Framingham and jackson heart study cohorts. Am J Hum Genet. 2012;91(3):513–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249–54.

Article  PubMed  Google Scholar 

Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Management of hypertrophic cardiomyopathy: JACC state-of-the-Art review. J Am Coll Cardiol. 2022;79(4):390–414.

Article  PubMed  Google Scholar 

Maron MS, Hellawell JL, Lucove JC, Farzaneh-Far R, Olivotto I. Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States. Am J Cardiol. 2016;117(10):1651–4.

Article  PubMed  Google Scholar 

Bai Y, Zheng JP, Lu F, Zhang XL, Sun CP, Guo WH, et al. Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China. Sci Rep. 2022;12(1):18799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butters A, Lakdawala NK, Ingles J. Sex differences in hypertrophic cardiomyopathy: interaction with genetics and environment. Curr Heart Fail Rep. 2021;18(5):264–73.

Article  PubMed  PubMed Central  Google Scholar 

Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54(3):201–11.

Article  CAS  PubMed  Google Scholar 

Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326(17):1108–14.

Article  CAS  PubMed  Google Scholar 

Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003;42(5):882–8.

Article  PubMed  Google Scholar 

Olivotto I, Cecchi F, Yacoub MH. Myocardial bridging and sudden death in hypertrophic cardiomyopathy: salome drops another veil. Eur Heart J. 2009;30(13):1549–50.

Article  PubMed  Google Scholar 

Mahrholdt H, Seitz A. Refining the prognostic value of LGE in hypertrophic cardiomyopathy: presence, extent, and location-what’s next? JACC Cardiovasc Imaging. 2023;16(9):1178–80.

Article  PubMed  Google Scholar 

Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, He Y. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging. 2016;9(12):1392–402.

Article  PubMed  Google Scholar 

McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47(3):532–8.

Article  CAS  PubMed  Google Scholar 

O’Mahony C, Elliott P, McKenna W. Sudden cardiac death in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6(2):443–51.

Article  PubMed  Google Scholar 

Tower-Rader A, Kramer CM, Neubauer S, Nagueh SF, Desai MY. Multimodality imaging in hypertrophic cardiomyopathy for risk stratification. Circ Cardiovasc Imaging. 2020;13(2):e9026.

Article  PubMed  PubMed Central  Google Scholar 

Spirito P, Autore C, Rapezzi C, Bernabo P, Badagliacca R, Maron MS, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119(13):1703–10.

Article  PubMed  Google Scholar 

Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, Maron MS. Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management. J Am Coll Cardiol. 2017;69(7):761–73.

Article  PubMed  Google Scholar 

Spirito P, Rapezzi C, Autore C, Bruzzi P, Bellone P, Ortolani P, et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation. 1994;90(6):2743–7.

Article  CAS